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ABSTRACT
Osteoblast (OB) lineage cells are an important source of vascular endothelial growth factor (VEGF), which is critical for bone
growth and repair. During bone development, pubertal differences in males and females exist, but little is known about
whether VEGF signaling contributes to skeletal sexual dimorphism. We have found that in mice, conditional disruption of
VEGF in osteocalcin‐expressing cells (OcnVEGFKO) exerts a divergent influence on morphological, cellular, and whole bone
properties between sexes. Furthermore, we describe an underlying sexual divergence in VEGF signaling in OB cultures in
vitro independent of circulating sex hormones. High‐resolution synchrotron computed tomography and backscattered
scanning electron microscopy revealed, in males, extensive unmineralized osteoid encasing enlarged blood vessel canals and
osteocyte lacunae in cortical bone after VEGF deletion, which contributed to increased porosity. VEGF was deleted in male
and female long bone–derived OBs (OBVEGKO) in vitro and Raman spectroscopic analyses of mineral and matrix repertoires
highlighted differences between male and female OBVEGFKO cells, with increased immature phosphate species prevalent in
male OBVEGFKO cultures versus wild type (WT). Further sexual dimorphism was observed in bone marrow endothelial cell
gene expression in vitro after VEGF deletion and in sclerostin protein expression, which was increased in male OcnVEGFKO
bones versus WT. The impact of altered OB matrix composition after VEGF deletion on whole bone geometry was assessed
between sexes, although significant differences between OcnVEGFKO and WT were identified only in females. Our results
suggest that bone‐derived VEGF regulates matrix mineralization and vascularization distinctly in males and females, which
results in divergent physical bone traits. © 2019 The Authors. Journal of Bone and Mineral Research published by Wiley
Periodicals, Inc.
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Introduction
Vascular endothelial growth factor (VEGF) is an endothelialcell (EC) survival factor and plays a central role in the
coupling of angiogenesis and osteogenesis.(1,2) Bone‐forming
osteoblast (OB) cells are a predominant source of VEGF in
bone and produce VEGF in response to a range of factors,
including hypoxia, mechanical strain, and estrogen.(3,4)
Although autocrine and/or direct effects of VEGF on OB dif-
ferentiation remain disputed in the literature,(3) intracrine
VEGF signaling has been reported and linked to early osteo-
blast lineage commitment.(1,5) Today, osteoblast and vascular
endothelial cells are known to be heterogeneous in devel-
oping bone, with immature and mature osteoblast pop-
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ulations interacting distinctly with the bone vasculature.(6) In
addition to its importance in maintenance of bone homeo-
stasis,(1) pre‐osteoblast‐derived VEGF has demonstrated to be
critical in the process of fracture repair.(4,7) Furthermore, the
vasculature appears to play a contributing role in age‐related
skeletal pathologies, and it has been shown that circulating
VEGF levels in postmenopausal women are reduced.(8)
There is an acknowledged divergence in age‐related fracture
risk between men and women, which is thought to reflect in-
herent differences in the control of bone growth and devel-
opment experienced between the onset of puberty and young
adulthood. During development, changes in bone geometry
are observed to be greater in males than females.(7,9–11) Males
produce a larger skeleton, which is postulated to protect them
from fracture in later life(11–14); however, the underlying
mechanisms regulating mineralization during skeletal sexual
dimorphism remain poorly understood. Estrogen and androgen
therapy have longstanding positive effects on bone mass, but
their efficacy is limited in cases of severe osteoporosis.(15) Thus,
identifying whether genetic mechanisms exist and contribute
to osteoporosis is of growing importance.
Given the pivotal role of VEGF in coupling osteogenesis and
angiogenesis, the aim of this study was to improve our un-
derstanding of VEGF signaling in the context of skeletal sexual
dimorphism. Herein, we have compared the effects of osteo-
calcin‐specific VEGF deletion in regulating male and female
osteoblast matrix production, mineralization, and linked this to
whole bone phenotypes.
Materials and Methods
Animal derivation and genotyping
Second‐generation osteocalcin‐specific VEGF knockout mice
(OcnVEGFKO) were produced by mating first‐generation VEGFfl/fl
mice with a single allele of osteocalcin Cre (Jackson Laboratory,
Bar Harbor, ME, USA) and VEGFfl/fl mice (Genentech, San Fran-
cisco, CA, USA). Tibiae were collected from either 4‐ or 16‐week‐
old male and female mice and fixed in 4% paraformaldehy
de (PFA). Skulls were frozen at –80 °C for µCT. To confirm con-
ditional knockout of VEGF, genomic DNA was extracted from tail
tips and genotyping performed as previously described.(5) Use of
animal tissue was carried out in compliance with Animals
Act 1986.
Micro‐computed tomography (µCT)
The Skyscan 1176 system (Bruker microCT, Kontich, Belgium)
was used to scan the entire tibia and skulls; X‐ray tube potential
of 45 kVp, X‐ray tube current of 556 µA, integration time of
375 ms, and voxel size of 18 µm. Slices were reconstructed,
processed, and analyzed as previously described.(16) A lower
threshold of 80 was used to separate bone from non‐bone.
Bone mineral density (BMD) was calculated by scanning a
phantom of known hydroxyapatite content using the same
conditions. The X‐ray attenuation coefficient was calculated in
CTAn and used to calculate the BMD for each animal. CTvox
(2.0) was used to determine bone threshold density within
the tibia, by loading the bone‐density heat map function and
using a standardized opacity for each bone. VGSTUDIO MAX
(Volume Graphics, Heidelberg, Germany) was used to create 3D
reconstructions of the skull scans. 2D images (Supplemental
Fig. S1A, B) were imported into ImageJ for quantitative bone
morphometry. For morphometric trabecular analysis, appear-
ance of the trabecular bridge that connected the two primary
spongiosa bone islands was set as a reference point for the
analysis of proximal tibia metaphyseal trabecular bone; 10% of
the total bone length from this point (towards diaphysis) was
utilized.
For high‐resolution scans (0.65 µm), synchrotron‐based CT
(SR CT) was conducted at the TOMCAT beamline of the Swiss
Light Source (Villigen, Switzerland), following previously
published methods.(17) Porosity was extracted in ImageJ by
thresholding two copies of the 300‐slice stack and inverting
one copy. The “keep largest region” function was used and
the stack eroded and dilated to create a mask. The image
calculator plugin “AND” function was then used to combine
the two images, leaving cortical porosity. Volumetric meas-
urements of the porosity were extracted using “particle
analysis” in ImageJ. Avizo (9.3.0; ThermoFisher Scientific,
Waltham, MA, USA) was used for separation of osteocyte
lacunae from vascular canals (open image file‐interactive
thresholding‐label analysis‐sieve analysis‐volume rendering)
and definition of threshold values. Individual absolute
threshold values were used for each animal, based on the
appearance of the first vascular canal. The threshold sepa-
rating lacunae and canals was therefore set just below the
volume of the smallest vascular canal (defined by shape and
size; see Supplemental Methods). Analysis of the thickness,
volume, and number for each fraction (osteocyte lacunae
and vascular canals) was performed using the “Analyze Par-
ticles” function in ImageJ and defined using previously
published nomenclature.(18)
Probability density distributions of lacunae volumes were
estimated using the ggplot2(19) package (version 2.2.1) in R
(version 3.3.3),(20) using a default bandwidth and 2048 estimate
points. The volume corresponding to the threshold separating
the two distinct populations of lacunae (low and high volume)
was identified, allowing comparisons of the proportion of os-
teocyte lacunae in the smaller fraction between groups.
Histochemistry
Contralateral left tibiae were prepared for histology as de-
scribed previously.(21) The Movat’s Pentachrome staining pro-
tocol was used to enable identification of blood vessels.(22) The
% blood vessel area was calculated using the freehand se-
lection tool on ImageJ (for area measurements).
Scanning electron microscopy (SEM)
PMMA blocks created for histology were polished and un-
coated surfaces imaged using a Zeiss EVO MA10 SEM operated
at 20 kV and 49 Pa chamber pressure with a four‐quadrant
backscattered electron (BSE) detector. Samples were treated to
remove bone matrix and mineral by successive application of
2N HCl and 7% chlorine sodium hypochlorite solutions, re-
moving calcified tissue and leaving a solid PMMA cast. To en-
able visualization of soft tissue, the surfaces of polished blocks
and casts were stained using either ammonium triiodide or
iodine vapor.(23,24)
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Osteoblast cell culture
Long bone osteoblasts (LOBs) were isolated from 4‐day‐old (P4)
male and female VEGFfl/fl mice using 10 mg/mL collagenase
and 4 mM EDTA, in a four‐step process.(25)
Endothelial cell culture
Primary murine bone marrow endothelial cells were purchased
from Generon (Slough, UK) and cultured according to manu-
facturer’s guidelines.
In vitro deletion of osteoblast‐derived VEGF
Once 80% confluent, LOBs were treated with adenovirus‐
Cre‐GFP (Vector Laboratories, Burlingame, CA, USA) in growth
media containing 10% FBS for deletion of VEGF or adenovirus‐
GFP as a control at a multiplicity of infection of 100 for
6 days.(26) For cell viability/proliferation only, LOBs were treated
with Adenovirus‐Cre‐GFP (denoted OBVEGFKO) and Ad-
enovirus‐GFP (denoted WT) for 24 hours. For collection of
conditioned media (CM), cells were stepped down in low‐
serum media (1%) for 24 hours.
Cell viability/proliferation assay
Cells were plated at a density of 2500 cells per well and cul-
tured for 24 hours for Cell Titer‐Glo 2.0 ATP assay (Promega,
Madison, WI, USA) and BrdU Cell Proliferation ELISA (Abcam,
Cambridge, UK).
Alkaline phosphatase (ALP) analysis
Osteoblasts were plated at a density of 50,000 cells per well
and left for 2 days to reach confluence. After incubation with
adenovirus, they were fixed in ethanol and methanol: acetone
for the ALP elution and staining, respectively, as described in
the literature.(27)
Automated cell counts
Cells were cultured on poly‐L‐lysine‐coated (50 µg/mL, 30,000
to 70,000 Mw) quartz coverslips (UQG Optics [Cambridge, UK]
CFQ‐1017 #1.5, thickness 0.17 mm, Ø 10 mm) at a density of
10,000 cells, in preparation for Raman spectroscopy. After in-
fection, cells were fixed with 4% paraformaldehyde and stained
with Hoechst 33342 at a concentration of 100 ng/mL in the
dark for 15 minutes. Images of fluorescent nuclei were acquired
using the Deltavision Elite microscope at 10×magnification (GE
Healthcare Life Sciences, Piscataway, NJ, USA) in combination
with the SoftWoRx software and counted using ImageJ.
Raman spectroscopy
Coverslips were prepared by sterilization in 100% ethanol before
incubation in poly‐L‐lysine solution for 2 hours at 37 °C before
being irradiated with UV light before plating. Cells were fixed in
4% PFA before spectral acquisition. Raman spectra were ac-
quired using a Renishaw inVia Raman microscope equipped with
a 532 nm laser and a Leica 63X water‐immersion microscope
objective (NA of 1.2). Spectra were collected in the “Fingerprint
region” from 600 cm−1 to 1750 cm−1. We have previously
identified a range of protein bands associated with collagen and
the extracellular matrix,(27) which were also identified in this
study and included CH2 deformation at 1450 cm
−1, amide III, and
amide I. Mineral bands were also detected, namely v1PO4
3‐
(959cm−1), in addition to other weaker phosphate bands be-
tween 948 and 970 cm−1. Raman spectra were collected from
the cytoplasm of 10 single cells, at five points around the
distinctly visible nucleus with an exposure time of 20 seconds
and three accumulations. Cosmic ray artefacts and background
contribution from quartz were removed using WiRE 4.1. Pre-
processing steps including wavelet denoising and background
correction by fitting of a 9th‐order polynomial, were performed
using iRootLab.(28) Class means were normalized to the Raman
peak at 1004 cm−1, corresponding to phenylalanine before de-
convolution analysis using WiRE 4.1 as previously described.(27)
qPCR and qPCR endothelial array
Total cell RNA was reverse transcribed, according to the man-
ufacturer’s instructions (Invitrogen, Carlsbad, CA, USA) and
qPCR undertaken (Supplemental Table S1) using an annealing
temperature of 60 °C. Ar, Esr1, and Esr2 primers were obtained
from Biomol GmbH (Hamburg, Germany), and the remainder of
sequences described were from Sigma (St. Louis, MO, USA).
Expression levels were calculated using delta delta Ct values
relative to GAPDH. The qPCR endothelial array described was
from Qiagen (Valencia, CA, USA).
Western blot analysis
LOBs and MBMEC were plated at density of 250,000 cells per
35 mm dish, protein lysed and used for Western blotting, as
previously described.(29) VEGFR2 and GAPDH rabbit mono-
clonal antisera were from Cell Signaling Technology (Danvers,
MA, USA) and incubated 1:1000 in 3% BSA at 4 °C overnight.
Immunohistochemistry
Tibiae were dissected and bones fixed in methanol‐free 4% PFA
for 4 hours (4 °C). A 0.5 M EDTA solution was used for decal-
cification of the tibiae, followed by treatment with a solution of
20% sucrose, 2% polyvinylpyrrolidone in PBS at 4 °C. Tibiae
were cryo‐embedded and 30 µm sections cut. Sections were
permeabilized (0.3% Triton PBS) and blocked with 5% donkey
serum, then incubated with sclerostin (SOST) primary antibody
(R & D Systems, Minneapolis, MN, USA; 1:50) overnight (4 °C).
Alexa Fluor 555 donkey anti‐goat (Invitrogen) was used as a
secondary antibody (1:300). For CD31 primary (BD Biosciences,
San Jose, CA, USA; 1:40) sections were incubated overnight
(4 °C). Alexa Fluor 488 goat anti‐rat (Invitrogen) was used as
secondary (1:400). Nuclei were stained with Hoechst 33342
(Invitrogen; 1:10,000) and sections mounted using Fluo-
romount G. Imaging was performed using a Zeiss Axioplan2
microscope.
Statistics
For micro‐CT analysis in which direct comparisons between sex
and genotype were made, two‐way ANOVA was employed. For
WT versus OcnVEGFKO comparisons, one‐tailed paired t tests
were undertaken between littermate animals, with WT repre-
senting VEGFfl/fl.
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Results
Deletion of mature VEGF exerts sexually dimorphic
effects on cortical bone microstructure
To study the skeletal functions of osteoblast‐produced VEGF,
Vegfa was conditionally deleted in mature osteoblasts by
crossing mice carrying floxed Vegfa alleles with mice expressing
Cre recombinase under the control of the osteocalcin pro-
moter.(30,31) No gross anatomical alterations were observed
between 16‐week‐old Vegfa osteocalcin conditional knockout
mice (OcnVEGFKO) of both sexes (Fig. 1A, upper panel). Dele-
tion of VEGF did not alter male and female tail length versus
WT (Fig. 1B). Although male WT and OcnVEGFKOs were ob-
served to be significantly heavier than female WTs and Ocn-
VEGFKOs, no differences were found between genotypes of
either sex (Fig. 1C). The skull phenotype was assessed using 10
cranial measurements made from medium‐resolution µCT
scans (18 µm voxel size) in WT and OcnVEGFKO animals. Across
the entire skull, there were no obvious defects in ossification
when comparing male versus female and OcnVEGFKO versus
WT mice (Fig. 1A, lower panel). Craniometric measurements
taken at the intramembranous neural crest, intramembranous
mesoderm, and mandible were largely unaltered in Ocn-
VEGFKO versus WT males and females. Changes were detected
in the frontal length, which was significantly lower in the
OcnVEGFKOs versus WT females, and the bitemporal distance
was significantly lower in the OcnVEGFKO versus WT males
(Supplemental Fig. S1, Supplemental Table S2).
Whole bone µCT scans were performed at medium reso-
lution (18 μm voxel size) on tibiae from OcnVEGFKO and WT
animals. Although no obvious differences were apparent in
OcnVEGFKO versus WT females, severe and extensive porosity
was evident particularly in male OcnVEGFKOs (Fig. 1D, arrows;
Supplemental Fig. S2 reveals fracture callus evident in one male
OBVEGFKO animal; see video). At this resolution, the poorly
mineralized bone phenotype was most evident in the epiphysis
and the tibiofibular junction (Fig. 1D). Tibial length was
significantly increased in OcnVEGFKO versus WT male mice
(Fig. 1E).
The capabilities of standard lab‐based μCT can be sig-
nificantly extended when synchrotron sources (SR) are used as
the actual X‐ray source.(32) High‐resolution (0.65 μm voxel size)
SR CT of the tibiofibular junction (Fig. 1D; box represents area
scanned) revealed severe cortical porosity, particularly evident
in the OcnVEGFKO male versus WT tibiae (Fig. 1F, G). Intra-
cortical porosity (Ct.Po, %) was not significantly increased in
OcnVEGFKO females (Fig. 1F); however, a large, significant in-
crease was present in OcnVEGFKO males compared with WT. A
significant increase in cortical porosity was also found in Ocn-
VEGFKO males versus females.
High‐resolution synchrotron X‐ray tomography revealed
sexual divergence in vascular canal and lacunar
phenotype after deletion of mature osteoblast‐derived
VEGF in adult mice
After SR CT, the intracortical canal network and osteocyte la-
cunae were extracted as a negative imprint of the calcified
tissue from CT data sets.(17,21,33–37) Using individual separation
thresholds detailed (Supplemental Methods and Supplemental
Table S3), 3D representations of the osteocyte lacunae (yellow)
and intracortical canals (red) were generated as two different
categories of the intracortical porosity (Fig. 2A, B). Typically, in
WT female animals, 75.8% of the total pore volume represented
osteocyte lacunae and 22.0% intracortical canals (Fig. 2C). In WT
males, 75.4% of the pore volume consisted of osteocyte la-
cunae and 23.1% intracortical canals (Fig. 2D). In OcnVEGFKO
female animals, the ratio of lacunae versus canals was similar;
however, in OcnVEGFKO males, a switch in the ratio of osteo-
cyte lacunae to intracortical canals was identified, with the
canal fraction accounting for 76.1% of the pore volume and
lacunae only 22.3% (with the remainder categorized as noise).
Upon quantification of the separate intracortical fractions
(Supplemental Table S3) OcnVEGFKO female mice displayed
significantly increased lacunar number density (Lc.Dn; Fig. 2E),
mean lacunar volume (Lc.V; Fig. 2F), and lacunar diameter
(Lc.Dm; Fig. 2G), compared with WT animals. In male Ocn-
VEGFKO animals, there were no significant differences evident in
the lacunar number density or mean lacunar volume, but a
decrease in lacunar diameter was observed (Fig. 2G).
To assess osteocyte size distribution between WT and Ocn-
VEGFKO animals, we undertook a particle distribution analysis using
the lacunar volumes. In WT female (Fig. 2H) and male (Fig. 2I)
animals, the probability density curves of osteocyte lacunae size are
dominated by a peak in the distribution above 200 μm3. In com-
parison, the OcnVEGFKO female animals (Fig. 2H) displayed larger
variation in lacunar volume between animals and a broader dis-
tribution curve. Male OcnVEGFKO animals (Fig. 2I) presented a
dramatically altered bimodal distribution, highlighting the presence
of two distinct populations of osteocyte lacunae, one containing
smaller lacunar volumes and one similar to WT volumes. The pro-
portion of osteocyte lacunae in this smaller volume population was
significantly greater in OcnVEGFKO males than in male WT
(p = 0.007) and female OcnVEGFKO mice (p = 0.015). No significant
difference in proportion was observed between OcnVEGFKO versus
WT females (Supplemental Table S4 for raw data values).
OcnVEGFKO male animals displayed a reduced canal
number density (Ca.Dn; Fig. 2J) and an increased mean canal
volume (Ca.V; Fig. 2K); however, mean canal diameter (Ca.Dm;
Fig. 2L) was unchanged. When using animal‐specific volume
thresholds (Supplemental Table S3 and Supplemental Fig. S3),
where intracortical canals appear only at mean volumes
greater than 7507 μm3 in OcnVEGFKO males (versus 1739 μm3
in WT animals), the current studies confirm there are sig-
nificantly fewer but larger intracortical canals present in the
tibiae of OcnVEGFKO male animals.
High‐resolution synchrotron X‐ray tomography revealed
sexual divergence in vascular canals after deletion of
mature osteoblast‐derived VEGF in prepubertal mice
Androgen and estrogen bioactivity levels have been reported
to increase between 5 and 7 weeks of age in male and female
C57BL6 mice, respectively.(38) The OcnVEGFKO cortical bone
phenotype at 4 weeks of age (Supplemental Fig. S4A–J), where
the levels of sex hormones will be similar,(38) was also exam-
ined. Some sexual dimorphism was observed, specifically in
Ca.V in male OcnVEGFKO versus females at 4 weeks of age
(Supplemental Fig. S4I). In addition, significant increases in the
canal fraction (% volume of total porosity) were observed in
male OcnVEGFKO versus WT and reduction in lacunae fraction
(% volume of total porosity) in male OcnVEGFKO versus WT.
The 4‐week‐old morphological cortical synchrotron CT data are
summarized along with 16‐week‐old data (Supplemental
Table S5).
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Fig. 1. Conditional deletion of VEGF alters bone formation in adult tibiae. No gross anatomical differences were evident between OcnVEGFKO versus
WT animals at 16 weeks of age (A; scale bar = 1 cm). Similarly, tail length (cm) was not significantly different between OcnVEGFKO and WT groups (B).
No significant differences in the weight (g) of male OcnVEGFKO versus WT were observed (C) (B, C, n = 6–8 animals from 5 individual litters, presented
as mean measurements ±SEM *p < 0.05, ****p < 0.0001 using two‐way ANOVA). Whole bone scans (D; 18 μm resolution) revealed poorly mineralized
regions of the OcnVEGFKO tibia localized to the epiphysis and the tibiofibular junction (arrows) specifically in male animals. Tibial length (mm) was
significantly greater in male OcnVEGFKO than WT (E; n = 4 males and 4 females from individual litters presented as mean ±SEM *p < 0.05 using two‐
way ANOVA). Total volume porosity (F) was calculated after reconstruction of 300 SRCT slices lacunae (error bars indicate mean value ±SEM, n = 3
females and 3 males from individual litters ****p < 0.0001 using two‐way ANOVA). High‐resolution, synchrotron X‐ray computed tomography (SRCT)
(G; 0.65 μm) slices from female and male WT and OcnVEGFKO mice revealed poorly mineralized areas of cortical bone at posterior region of
tibiofibular junction (G; white arrows) and differences in cortical porosity between male and female OcnVEGFKO. Scale bar = 200 µm.
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Fig. 2. Continued.
Effect of mature osteoblast‐derived VEGF deletion on
vascular and osteocyte phenotype
BSE‐SEM imaging was used to enable identification of the
cellular components of the bone cortex at the tibiofibular
junction, and after erosion of the bone mineral with HCl and
bleach (NaOCL), the cortical vasculature was revealed (Fig.
3A–D). No differences were apparent between WT (Fig. 3A) and
OcnVEGFKO females (Fig. 3B) after HCl and NaOCL treatment. In
contrast to females and consistent with the porous phenotype
observed in OcnVEGFKO mice after SR CT imaging, we ob-
served vascular canals densely populating the bone cortex in
OcnVEGFKO males in marked contrast to WT animals (Fig. 3C).
Lack of mineral directly surrounding the vasculature was evi-
dent in OcnVEGFKO males (Fig. 3D), and after HCl/NaOCL
treatment, large areas of PMMA were retained because of the
extensive overlapping of osteocytes covering the blood vessels
and poor mineralization. This phenotype highlighted a lack of
matrix organization within the cortical bone of OcnVEGFKO
males, closely resembling woven bone, which is characteristi-
cally laid down rapidly and provides a structural scaffold for
processes such as fracture healing.
BSE SEM imaging of PMMA‐embedded tibiae stained with
ammonium triiodide enabled examination of the effect of VEGF
deletion on matrix mineralization longitudinally. As observed in
the cross‐sectional images, in OcnVEGFKO female tibia sections,
the bone cortex appeared comparable to WT animals (Sup-
plemental Fig. S5A). In contrast, in OcnVEGFKO male bones, the
bone was not mineralized efficiently and extensive areas of
osteoid in the cortex surrounding the blood vessels and os-
teocytes (Supplemental Fig. S5B).
The poorly mineralized and highly vascularized phenotype
present in the tibia of OcnVEGFKO males was further verified by
histology (Fig. 3A–D), using Pentachrome staining to dis-
tinguish between nonmineralized (red) and mineralized com-
ponents (green) of the bone. A significant increase was
highlighted in the area of vascular canals in OcnVEGFKO males
versus WT animals (Fig. 3E). Vascular canal occupancy was also
assessed, but no significant differences were identified (Fig. 3F).
Similar to the BSE imaging of OcnVEGFKO males after HCL/
NaOH treatment, Pentachrome staining revealed large areas of
unmineralized osteoid surrounding blood vessel canals and
osteocyte lacunae (Fig. 3D), which contributed to the elevated
pore volume detected by SR CT. To identify matrix components
of the perivascular and lacunar osteoid detected by the Pen-
tachrome stain, Raman spectroscopy was utilized (Fig. 3G) and
confirmed that this region was completely devoid of hydrox-
yapatite in contrast to the mineralized bone matrix (stained in
green). No difference in endosteal remodeling was observed
between OcnVEGFKO versus WT (Supplemental Fig. S6).
Effects of osteoblast‐derived VEGF deletion on
trabecular bone
Given the extent of the mineralization defect observed in the
cortical bone after VEGF deletion, we also analyzed trabecular
bone phenotype (Supplemental Fig. S7A–E). No sexual di-
morphism was observed in any trabecular bone parameters in
OcnVEGFKO animals versus WT at 4 weeks (BV/TV, % bone
volume; BS/TV, bone surface area; Tb.Th, trabecular thickness;
Tb.N, trabecular number). At 16 weeks, a significant reduction
in trabecular number (Tb.N (1/U)) was observed in female
OcnVEGFKO versus WT (Supplemental Fig. S7E).
In vitro VEGF deletion in osteoblasts does not alter
endothelial cell viability or proliferation
To investigate the role that sex hormones may play in the
sexual divergence of the in vivo phenotype observed, we un-
dertook in vitro experiments to remove the effects of circu-
lating sex hormones. The experimental approach centered
around deletion of VEGF from osteoblasts (using adenoviral cre
recombinase; OBVEGFKO) isolated from the long bones of
postnatal day 4 (P4) male or female VEGFfl/fl animals (WT). We
subsequently investigated indirect paracrine effects on bone‐
marrow endothelial cell behavior.
Endothelial cells express high levels of VEGFR2 protein in
vitro,(29) and a paracrine communication has been hypothesized
between the vascular endothelium and OBs and indirect effect
of VEGF on osteoblast via endothelial cells reported.(29) Herein,
we sought to establish whether any sexually dimorphic mech-
anisms regulating the OBVEGFKO bone phenotype are driven
indirectly by vascular endothelial cells. In vitro conditioned
media (CM) experiments utilizing male and female LOBs with
VEGF‐deleted and murine bone marrow endothelial cells
(BMECs) were used to examine this mechanism (Fig. 4A).
Although VEGF deletion was >90% in both female and male
OBVEGFKO cultures (Fig. 4B), OBVEGFKO CM did not alter en-
dothelial cell proliferation (Fig. 4C) or cell viability (Fig. 4D) versus
WT. Surprisingly, MBMECs treated with male and female OB-
VEGFKO CM for 5 minutes displayed enhanced levels of VEGFR2
protein versus WT (Fig. 4E), which may be reflective of higher
VEGF levels present in WT LOBs (Fig. 4B), potentially inducing
internalization of the VEGFR2. In contrast, after 24 hours of ex-
posure of male and female OBVEGFKO CM, VEGFR2 protein
levels in MBMECs were reduced versus WT (Fig. 4E), suggesting
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Fig. 2. Distinction of bone porosity components is compromised after VEGF deletion in males. 3D renderings of osteocyte lacunae (yellow) and
intracortical canals (red) from female (A) and male (B) WT and OcnVEGFKO mice (16 weeks old) after SRCT scans (0.65 μm voxel size). Scale bar = 50 µm.
In WT male and female animals, osteocyte lacunae made up the highest fraction of the intracortical porosity (C). In male OcnVEGFKO, % pores
constituting the intracortical canal fraction was increased versus WT (D). Measurements taken of regularly sized osteocyte lacunae show an increase in
lacuna number density (Lc.Dn; E), mean lacunar volume (Lc.V; F), and mean lacunar diameter (Lc.Dm; G) in female OBVEGFKO versus WT. In males, there
was a decrease in mean lacunar diameter (Lc.Dm; G) after knockout of OBVEGF. The probability density of osteocytes of different volumes for females (H)
and males (I) are shown by graphs on a logarithmic scale, which were created using the free language and environment for statistical computing and
graphics R (https://cran.r‐project.org/). Each colored line represents one animal. Number of intracortical canals greater than the lacunar threshold (see
Materials and Methods) is significantly decreased in male OcnVEGFKO (Ca.Dn; J). An increase in mean canal volume was observed after OcnVEGFKO
(Ca.V; K); however, no change in mean canal diameter was observed in male OcnVEGFKO (Ca.Dm; L). Error bars indicate mean value ±SEM, n = 3 females
and 3 males from individual litters *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 using two‐way ANOVA.
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Fig. 3. Conditional VEGF deletion increases blood vessel area and unmineralized osteoid in males. No obvious differences in bone architecture are
found between female WT (A) and OcnVEGFKO bones (B) in either the SEM images (left; scale bar = 100 µm) or the pentachrome‐stained bone
sections (right; scale bar = 20 µm). SEM shows very few blood vessels remaining in both the WT and OcnVEGFKO after treatment with HCl and NaOCL.
There are minimal areas of osteoid surrounding the BV canals and osteocyte lacunae. In comparison to male WT (C), in OcnVEGFKO bones (D),
increased vascularization (red arrows) was present and visible in SEM images after treatment with HCl and NaOCL (left) and in pentachrome‐stained
images (right). The close proximity and overlapping of the osteocytes surrounding the bone marrow (BM) and the poor mineralization result in large
amounts of PMMA remaining. In histologically stained male OcnVEGFKO sections, there were large amounts of unmineralized osteoid (*) surrounding
BV canals (hatched lines). Analysis of stained sections showed that OcnVEGFKO versus WT % area BV canals (E) was increased in males. There was a
high level of vascular canal occupancy (F), which remained unchanged in OcnVEGFKO versus WT animals (error bars indicate mean value ±SEM, n = 4
female and n = 3 male mice from individual litters, **p < 0.01 using two‐way ANOVA). Raman spectroscopy revealed a lack of hydroxyapatite (HA) in
perivascular regions versus cortical bone (G).
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Fig. 4. Sexually dimorphic effects of VEGF deletion on endothelial cell function. Mouse bone marrow endothelial cells (MBMECs) were treated with LOB
conditioned media (CM) from male and female WT and OBVEGFKO cells for 24 hours (A). VEGF ELISA confirms VEGF deletion (B; three separate experiments
±SEM, *p < 0.05 using t test). For proliferation (BrDU; C) and viability (ATP; D) assays, MBMECs were treated for 24 hours with WT or OBVEGFKO CM with low‐
serum (1%) media (–) and high serum (10%; +) used as controls. Data represent n = 6 replicates ±SEM, **p < 0.01, ****p < 0.0001 using t test. For VEGFR2
expression, MBMECs were treated for either 5 minutes or 24 hours and total VEGFR2 protein assessed by Western blotting (E). Gene expression changes were
assessed by endothelial qPCR array with heat maps representing expression changes (fold change) of 84 different genes after the treatment of MBMEC with
male and female OBVEGFKO and WT conditioned media (F). Table summarizes changes in gene expression in both sexes (G).
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Fig. 5. Continued.
that long‐term deletion of OBVEGF could impact endothelial cell
sensitivity to VEGF. These results suggest that the sexual di-
morphic effect observed in the vasculature in vivo, after OB-
VEGFKO is either 1) not linked to altered endothelial cell viability,
proliferation, or VEGFR2 expression and/or that 2) sex steroids
and mechanical or environmental factors are required to induce
the vascular effects observed in vivo. To investigate this further,
we undertook an “endothelial” qPCR array to assess alterations in
BMEC endothelial cell gene expression. After 24 hours of ex-
posure to male and female OBVEGFKO CM, widespread sexually
divergent alterations in BMEC gene expression versus WT CM
were observed (Fig. 4F). Angiogenic growth factors such as
transforming growth factor‐β1 and placental growth factor
mRNA were both upregulated (+1.5‐fold and +2.26‐fold, re-
spectively) in BMEC treated with male OBVEGFKO conditioned
media versus WT but reduced after treatment with female
OBVEGFKO media (–1.01 and –1.46, respectively). In addition,
mRNA expression levels were upregulated for a number of ad-
hesion molecules including VCAM (+1.43) and PECAM (+2.03) in
BMECs treated with male OBVEGFKO CM versus WT, which may
contribute to the increased vasculature observed in vivo after
VEGF deletion. Other genes that may affect vascular function
which were downregulated in ECs treated with male OBVEGFKO
media include P‐selectin (–1.42) and thymidine phosphorylase
(tymp), FGF1 (–1.13), and FGF2 (–1.01). Sex steroids and the
growth hormone–insulin‐like growth factor 1 (IGF1) axis have
been shown to interact closely during puberty,(39) and IGF‐1 has
previously been reported to be a primary determinant of the
development of the skeletal dimorphism. Interestingly, we have
found that IGF‐1 is upregulated in BMECs treated with female
OBVEGFKO media (+3.07) and which is conversely down-
regulated in BMECs treated with male OBVEGFKO media (–2.33)
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Fig. 5. Direct effects of VEGF deletion on male and female osteoblast function. VEGF was deleted in vitro in male and female LOBs (P4). No differences
in viability (ATP; A) versus WT were evident from males or females. Control cells received low‐serum media (–) Wnt3a (75 ng/mL +). Data represent
mean value from six individual infections ±SEM, ***p < 0.001, ****p < 0.0001 using t test. Significant increases were found in alkaline phosphatase
(B) after OBVEGFKO (C; scale bar = 100 µm). Control cells received 10% FBS media (–) and 10% FBS containing β‐glycerol‐phosphate (+). Data
represent mean value from three individual infections ±SEM, **p < 0.01, ***p < 0.001 using t test. Knock‐down efficiency was further confirmed using
qPCR (D) for VEGF mRNA in male and female OBVEGFKOs. The involvement of osteoclasts in the phenotype was investigated looking at relative
expression of OPG (E) and RANKL (F), where no significant changes were identified after OBVEGFKO. Raman spectroscopy was able to detect clear and
significant sex differences (between immature (ACP; G), intermediate (OCP; H), and mature (CAP; I) calcium species in WT and OBVEGFKO cells.
Mineral/matrix ratio also shows a significant increase in matrix maturity after OBVEGFKO in females, whereas the converse is exhibited in males (J).
Schematic representation of the changes in calcium phosphate species in WT and OBVEGFKO cells are shown (K). Error bars indicate mean value
±SEM, **p < 0.01, ****p < 0.0001 using t test, n = 50 spectra from each treatment group. Cell number increased over time in culture (****p < 0.0001)
in both sexes but was not affected by OBVEGFKO (L). Data represent mean number of nuclei per µm2 ±SEM, ****p < 0.0001 using two‐way ANOVA,
n = 20 fields of view per group. No notable changes in gene expression of androgen receptor (Ar; M), estrogen receptor 1 (Esr1; N), or estrogen
receptor 2 (Esr2; O) were evident in males and females after OBVEGFKO.
Fig. 6. Sexual dimorphic alterations in protein expression of SOST after VEGF deletion are evident in whole bone sections. Cryosections from female
(A) and male (B) WT and OcnVEGFKO tibiofibular junction were stained with sclerostin primary antibody and Hoechst to stain the nuclei. Increases in
sclerostin levels were visible after OcnVEGFKO in males (Alexa Fluor 555), specifically in the posterior region (arrows) below the bone marrow (BM).
White box represents the region of cortical bone magnified below. Scale bar = 100 µm.
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Fig. 7. Significant alterations in tibial geometry after bone‐derived VEGF deletion is evident only in females. Minimum and maximum second
moments of inertia (Imin and Imax, respectively), cross‐sectional area, resistance to torsion (J), ellipticity, cortical thickness, and bone mineral density
(BMD) of male and female OcnVEGFKO tibiae versus WT at 16 weeks of age (A). Graphical heat map summarizes statistical differences (using ANOVA)
at specific matched locations along the tibial length (10% to 90%), representative of overall effect of genotype. Red p ≤ 0.0001, yellow
p ≤ 0.001–0.01, green p ≤ 0.01–0.05, and blue p ≥ 0.05. Line graphs represent means for female (B) and male (C) WT versus OcnVEGFKO ±SEM (n = 4
female and 4 male mice from individual litters). Longitudinal tibial cross sections created using CTvox show a decrease in bone density in OcnVEGFKO
females (D) and an increase in bone density in OcnVEGFKO males (E). Heat map scale plotted from 0 (brown; low‐threshold density) to 255 (blue; high‐
threshold density).
and thus potentially contributing to the skeletal phenotype
observed (Fig. 4G).
In vitro VEGF deletion induces distinct matrix and
mineralization signatures in male and female osteoblasts
To investigate whether the observed defect in mineralization in
male OBVEGFKO mice was driven by direct effects of VEGF on
LOB function, we deleted VEGF with adenovirus‐Cre‐GFP as
previously described.(26) Consistent with our previous work,(29)
LOBs did not express detectable levels of VEGFR2 protein or
mRNA (Supplemental Fig. S8A, C). This was similar to the in-
formation derived from immunohistochemical labeling of bone
sections for VEGFR2, which co‐localized only with CD31 endo-
thelial cells (Supplemental Fig. S8B) and was further validated
by qPCR (Supplemental Fig. S8C).
Deletion of VEGF did not impact male or female LOB viability
(Fig. 5A). However, in contrast, deletion of VEGF in both male
and female LOBs significantly increased ALP activity (Fig. 5B, C),
suggestive of autocrine/intracrine regulation given the lack
of VEGFR2 expression. Reduced VEGF mRNA expression was
confirmed by qPCR after adenovirus‐Cre‐GFP treatment
(Fig. 5D). The potential communication of male and female
OBVEGFKO cells with osteoclasts was investigated by meas-
urement of OPG and RANKL mRNA levels, but no differences
were observed versus WT (Fig. 5E, F).
We have previously identified Raman spectroscopy as a highly
sensitive fingerprinting technique for specific detection of dif-
ferentiation changes in primary bone cell cultures.(27) Given its
enhanced sensitivity, we utilized Raman spectroscopy to identify
in detail any alterations in mineral and matrix components in
LOBs after VEGF deletion (Supplemental Fig. S9A). Raman spectra
(Supplemental Fig. S9B) were collected within the “fingerprint
region” and subsequent spectral peak analysis and assignment
was carried out on mean spectra. Upon analysis of female LOBs
with VEGF successfully deleted (Supplemental Fig. S9C,D), small
but significant changes in amorphous calcium phosphate (ACP)
(Fig. 5G) and octacalcium phosphate (OCP; Fig. 5H) (+1.77‐fold
and +1.21‐fold, respectively) were observed; however, the
largest fold change in mineral species was found in carbonated
apatite (CAP; Fig. 5I; +10.5‐fold). The mineral‐to‐matrix ratio in
OBVEGFKO female cells was also increased (Fig. 5J; +11.9‐fold),
suggesting that when VEGF is deleted, females exhibit a mature
mineral signature (Fig. 5J). Male OBVEGFKO cells had their largest
fold change evident in the levels of immature ACP (Fig. 5G,
K; +23.6‐fold), consistent with a small but significant decrease in
mineral‐to‐matrix ratio (Fig. 5J; –1.33‐fold). A reduction in OCP
was also evident in male OBVEGFKO cells (–1.17‐fold) with a
small significant increase in CAP (+1.24‐fold). To control for cell
number, male and female WT and OBVEGFKO cells were counted
at day 1 and day 7 after plating on quartz coverslips. No sig-
nificant differences in cell number were observed between sex
or genotype at each time point (Fig. 5L). To investigate whether
steroid signaling responses were involved in driving this sexually
dimorphic effect, we measured androgen receptor (Ar) and es-
trogen receptor 1/2 mRNA expression (Fig. 5M–O) in male and
female WT and OBVEGFKO cells. No significant differences were
identified across sex or genotype.
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Fig. 8. Sexually dimorphic effects of VEGF deletion on matrix mineralization and porosity link to whole bone phenotypes. Female OcnVEGFKO mice
are able to maintain porosity and vasculature but compromise tibial geometry after deletion of VEGF in osteoblast cells. In contrast, male
OcnVEGFKOs are able to maintain tibial geometry, despite increased cortical porosity associated with altered blood vessel configuration. Raman
spectroscopy has shown that this skeletal sexual dimorphism could be linked to direct effects of VEGF on OB matrix production, with increased
immature phosphate species (ACP) predominant in male OBVEGFKO cells.
Deletion of osteoblast‐derived VEGF increases sclerostin
expression in male bones
Given the mineralization defect described between male and
female OcnVEGFKO animals and cells, we investigated whether
expression levels of an established inhibitor of mineralization,
sclerostin (SOST), was influenced. Consistent with our CT and
histology analyses, cryo sections were cut at the tibiofibular
junction of WT and OcnVEGFKO male and female mice and
labeled with sclerostin antisera. In WT and OcnVEGFKO female
mice, sclerostin staining was observed to be low and localized
to osteocyte populations (Fig. 6A). In WT males, the levels of
sclerostin expression appeared highest at the tibiofibular
junction. In contrast, in OcnVEGFKO animals, sclerostin ex-
pression was high and widespread across cells within the entire
bone section (Fig. 6B).
Adult males conserve parameters of tibial geometry and
shape after OB VEGF deletion
After our observed alteration in matrix mineralization, we finally
sought to analyze the impact of OBVEGF deletion on whole
bone geometry and shape of male and female bones. A
graphical heat map representation of statistical significance of
the effect of VEGF deficiency on measures of bone mass and
shape (Fig. 7A), including measurements of cross‐sectional area
(CSA), minimum moment of inertia (Imin), maximum moment of
inertia (Imax), and cortical thickness (Ct.Th), ellipticity (bone
shape) and predicted resistance to torsion or polar moment of
inertia (J) identified significant differences at different points
along the tibial length in females only. Measures of bone mass
(CSA) and shape (J) are significantly compromised in female
(green; Fig. 7B), but not male (turquoise; Fig. 7C) OcnVEGFKO
mice compared with WT controls (grey). It appears that while
males compromise on bone porosity after OcnVEGFKO, tibial
geometry and mechanical properties of the bones are main-
tained. BMD measurements along the entire tibia were not
significantly different between male and female OcnVEGFKO
versus WT bones (Fig. 7A–C).
Correlating with these changes in bone geometry found
predominantly in females, analysis of longitudinal tibial cross
sections highlighted a decrease in bone threshold density in
females after OcnVEGFKO (Fig. 7D). In contrast, male tibiae
appear to compensate for the lack of VEGF, and an increase in
bone threshold density was observed after OcnVEGFKO (Fig. 7E).
Male versus female comparisons of bone geometry showed
basal differences in cross‐sectional cortical thickness in WT
animals (Supplemental Fig. S10A), with female bones sig-
nificantly thicker than in males at several points above and
below the tibiofibular junction. BMD measurements were not
significantly altered when comparing female versus male tibiae
(Supplemental Fig. S10A–C). After OcnVEGFKO, the sex differ-
ences in thickness at these specific regions were no longer
significant. In marked contrast to WT bones (Supplemental
Fig. S10B), OcnVEGFKO bone measurements (Supplemental
Fig. S10C) of CSA, Imin, Imax, Ct.Th, and J were significantly
greater in males versus females at several points along the
tibial length. The only exception to this is ellipticity, which was
significantly higher in female versus male OcnVEGFKO animals
at ~80% along the tibial length (Supplemental Fig. S10A).
As sexual dimorphism in vascular canal parameters were
evident by SRCT in 4‐week‐old male OcnVEGFKO mice. Whole
bone (tibial) geometry was also assessed in 4‐week‐old animals
(Supplemental Fig. S11A) and included CSA, Imin, Imax, Ct.Th,
ellipticity, and J. Significant differences in CSA, Imax, Ct.Th, and
ellipticity (Supplemental Fig. S11B) were identified in multiple
sites of male OcnVEGFKO versus WT.
Discussion
The current studies demonstrate that VEGF produced by os-
teocalcin‐positive cells exerts sexually dimorphic effects on
bone mineralization and vascularization, driven in part by direct
effects on OB differentiation potential (summarized in Fig. 8).
Using a range of approaches to assess the differences in cortical
bone architecture, we observed enhanced cortical porosity in
OcnVEGFKO males compared with females. Dimorphism in
porosity was demonstrated further with fewer, larger intra-
cortical canals and less osteocyte lacunae present in male
OcnVEGFKOs. The increase in canal volume in male Ocn-
VEGFKOs was associated with the appearance of two distinct
populations of osteocyte lacunae, one containing smaller la-
cunae and one of similar size to WTs. Extensive unmineralized
osteoid resembling immature woven bone was evident encir-
cling the intracortical blood supply and osteocyte lacunae in
male OcnVEGFKOs. We investigated this vascular defect further
in vitro, and a paracrine role for OB‐derived VEGF was evi-
denced via the sexually dimorphic alteration in pro‐angiogenic
gene expression of bone marrow–derived endothelial cells
after VEGF deletion. Direct effects of OB‐derived VEGF on OB
matrix were also evident in vitro in male OBVEGFKO cells pro-
ducing predominantly immature mineral precursors (amor-
phous calcium phosphate) versus mature mineral (carbonated
apatite) in female OBVEGFKO cells. The matrix alterations were
independent of circulating hormones and androgen and es-
trogen receptor mRNA expression levels and suggest an un-
derlying genetic influence. The failure for OBs to mineralize
efficiently was associated with enhanced SOST levels in male
OcnVEGFKO bones. Finally, our studies of whole bone geom-
etry revealed male OcnVEGFKOs maintained bone shape de-
spite increases in cortical porosity.
Our findings describe the concept that sexual dimorphism in
VEGF signaling was linked to production of matrix components
in bone controlled partly indirectly by alterations in endothelial
cell gene expression and also directly by osteoblast matrix
production. We have described how VEGF‐dependent sexual
dimorphism appears to underlie differences in phosphate
repertoires and unmineralized matrix components produced by
male and female‐derived osteoblasts in vitro, which may di-
rectly recapitulate in the mineralization defect described in
vivo. Endogenous VEGF has been shown to be critical in the
regulation of mineralization,(40–43) although VEGF effects have
never previously been addressed in the context of sexual di-
morphism. Our results show that bone‐derived VEGF can dif-
ferentially control rates of mineralization between male and
females, which could potentially support the different bone
growth rates of both sexes and underlie bone matrix compo-
sition in later life.
Vascular endothelial cells express high levels of VEGF receptor
2, and a paracrine role for OB‐derived VEGF has been proposed(3)
with endothelial cells known to produce osteogenic factors and
influence bone formation.(44,45) When VEGF was deleted in male
and female OB cultures, endothelial cell viability and proliferation
was maintained, suggesting that osteoblasts may produce other
angiogenic factors to compensate for the lack of VEGF, in order to
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support endothelial cell survival. Furthermore, endothelial cells
treated with male or female OBVEGFKO conditioned media al-
tered their gene expression in a sex‐specific manner, which in-
cluded increased IGF‐1 in females and decreased IGF‐1 levels in
males. Aside from growth factor production, it is also possible that
the sexually dimorphic vascular phenotype observed in vivo could
be due to alterations in the osteoblast matrix constituents im-
pacting angiogenesis directly. The extracellular matrix (ECM) is
known to control vascular ingrowth with the temporal and spatial
regulation of ECM remodeling providing a scaffold to control cell
growth, migration, and differentiation during different stages of
angiogenesis. ECM molecules are also emerging as key effectors
of SOST inhibition as they are thought to regulate the availability
of sclerostin to its osteoblastic targets.(46) The failure of Ocn-
VEGFKO male bones to mineralize effectively is consistent with
this idea as we have identified increased SOST protein expression
in the bones of these mice. Furthermore, in line with our ob-
servations that SOST effects appear to be sexually dimorphic,
Mödder and colleagues(47) reported a correlation between circu-
lating SOST levels with age, sex, and bone mass in a large pop-
ulation‐based study with men having higher serum SOST levels
than women with age.
Today the evidence supporting a role of VEGF in osteopo-
rosis exists and its requirement for fracture repair is well
documented. Bone shape, size, and density are accepted clin-
ical predictors of fracture susceptibility and single measure-
ments of bone mass are now thought to be ineffective in
predicting bone fragility. The effects of VEGF deficiency on
measures of bone mass and shape identified most significant
differences along the tibial length at 16 weeks only in female
OcnVEGFKO versus WT. Female OcnVEGFKO bones were
thinner, with a smaller cross‐sectional area and less resistance
to bending and torsional loading. In contrast, significant dif-
ferences were observed in OcnVEGFKO versus WT males at
4 weeks of age and included cortical thickness and ellipticity,
which were no longer present by 16 weeks. This indicates that
after the loss of bone‐derived VEGF, males may override early
alterations in bone shape at the expense of cortical porosity
into adulthood. Further, this implies that as adults, male
OcnVEGFKOs may either attempt to overcome the mechanical
instability associated with increased porosity by maintaining
bone shape or that bone porosity and bone shape are two
independently regulated mechanisms.
Sex differences in the skeleton are present in puberty,
adulthood, and old age, and a wealth of evidence has dem-
onstrated sex steroids as key regulators of bone health and
mechanical responsiveness throughout life. Our results are
relevant as they suggest systemic loss of VEGF, eg, with age
could impact bone health differently in men and women. Given
the current demonstration of sexual dimorphism in cortical
porosity and mineralization driven by VEGF in vivo and in vitro
at the cellular level, future studies should aim to isolate the
contribution of sex steroids completely by hormone depletion
in vivo after VEGF deletion. Such studies could reveal under-
lying sex‐specific genetic regulators of bone mineralization,
which could be targeted therapeutically. This is particularly
important in an aging demographic given the failure of hor-
mone replacement therapy to treat severe cases of osteopo-
rosis. Furthermore, these findings are extremely timely in the
context of increased prevalence of degenerative bone disease
in males and critically given reports of divergent sex effects on
post‐fracture mortality.(48,49)
Disclosures
All authors state that they have no conflicts of interest.
Acknowledgments
This study was funded by Versus Arthritis UK. We acknowledge
the Paul Scherrer Institut, Villigen, Switzerland for provision of
synchrotron radiation beamtime at TOMCAT beamline of the
Swiss Light Source. We would like to acknowledge the µ‐VIS
X‐ray Imaging Centre at the University of Southampton for
provision of tomographic imaging facilities, where image
analysis was performed. We would also like to thank Maureen
Arora for her help with the SEM, Simona Bolamperti for her
help with the immunohistochemistry and Cordula Erdmann for
her help with the histology. Stephanie Anderson’s contribution
to figure 3 is also gratefully acknowledged.
Authors’ roles: Study design: AG, CEC, AS, ROCO, and PS. Data
collection: AG, AS, JMK, and AB. Data analysis AG, AS, BJ, and
RCGS. Data interpretation: AG, AS, BJ, AB, EH, SM, BRO, AAP, PS,
ROCO, and CEC. Drafting manuscript: CEC, AG, and AS. Revising
manuscript content: CEC, AG, AS, ROCO, and PS. Approving
final manuscript: CEC, AG, AS, BJ, AB, EH, SM, BRO, AAP, PS,
ROCO, JMK, and RCGS. AG takes responsibility for the integrity
of the data analysis.
References
1. Liu Y, Olsen BR. Distinct VEGF functions during bone develop-
ment and homeostasis. Arch Immunol Ther Exp (Warsz).
2014;62:363–8.
2. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the po-
tential for engineering bone. Eur Cell Mater. 2008;15:100–14.
3. Clarkin CE, Gerstenfeld LC. VEGF and bone cell signaling: an es-
sential vessel for communication? Cell Biochem Funct. 2013;31:
1–11.
4. Hu K, Olsen BR. The roles of vascular endothelial growth factor in
bone repair and regeneration. Bone. 2016;91:30–8.
5. Liu Y, Berendsen AD, Jia S, et al. Intracellular VEGF regulates the
balance between osteoblast and adipocyte differentiation. J Clin
Invest. 2012;122:3101–13.
6. Maes C, Kobayashi T, Selig MK, et al. Osteoblast precursors, but not
mature osteoblasts, move into developing and fractured bones
along with invading blood vessels. Dev Cell. 2010;19:329–44.
7. Hu K, Olsen BR. Osteoblast‐derived VEGF regulates osteoblast dif-
ferentiation and bone formation during bone repair. J Clin Invest.
2016;126:509–26.
8. Senel K, Baykal T, Seferoglu B, et al. Circulating vascular endothelial
growth factor concentrations in patients with postmenopausal
osteoporosis. Arch Med Sci. 2013;9:709–12.
9. Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis
and osteogenesis by a specific vessel subtype in bone. Nature.
2014;507:323–8.
10. Costa N, Paramanathan S, MacDonald D, Wierzbicki AS, Hampson
G. Factors regulating circulating vascular endothelial growth factor
(VEGF): association with bone mineral density (BMD) in post‐
menopausal osteoporosis. Cytokine. 2009;46:376–81.
11. Martin RB. Size, structure and gender: lessons about fracture risk. J
Musculoskelet Neuronal Interact. 2002;2:209–11.
12. Seeman E. Clinical review 137: sexual dimorphism in skeletal size,
density, and strength. J Clin Endocrinol Metab. 2001;86:4576–84.
13. Seeman E. Pathogenesis of bone fragility in women and men.
Lancet. 2002;359:1841–50.
Journal of Bone and Mineral Research SEXUAL DIMORPHISM IN REGULATION OF BONE VASCULAR NETWORK 15 ◼
14. Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschueren D.
Skeletal sexual dimorphism: relative contribution of sex steroids,
GH‐IGF1, and mechanical loading. J Endocrinol. 2010;207:127–34.
15. Lacey DL, Boyle WJ, Simonet WS, et al. Bench to bedside: eluci-
dation of the OPG‐RANK‐RANKL pathway and the development of
denosumab. Nat Rev Drug Discov. 2012;11:401–19.
16. Mosey H, Nuñez JA, Goring A, et al. Sost deficiency does not alter
bone’s lacunar or vascular porosity in mice. Front Mater. 2017;4:27.
17. Nuñez JA, Goring A, Javaheri B, et al. Regional diversity in the murine
cortical vascular network is revealed by synchrotron X‐ray tomog-
raphy and is amplified with age. Eur Cell Mater. 2018;35:281–99.
18. Bouxsein ML, Boyd SK, Christiansen BA, et al. Guidelines for as-
sessment of bone microstructure in rodents using micro‐computed
tomography. J Bone Miner Res. 2010;25:1468–86.
19. RC Team. R: a language and environment for statistical com-
puting. 2011.
20. Wickham H. ggplot2: elegant graphics for data analysis. New York:
Springer‐Verlag; 2016.
21. Nuñez JA, Goring A, Hesse E, et al. Simultaneous visualisation of
calcified bone microstructure and intracortical vasculature using
synchrotron X‐ray phase contrast‐enhanced tomography. Sci Rep.
2017;7:13289.
22. Russell HK. Jr. A modification of Movat's pentachrome stain. Arch
Pathol. 1972;94:187–91.
23. Boyde A, McCorkell FA, Taylor GK, Bomphrey RJ, Doube M. Iodine
vapor staining for atomic number contrast in backscattered elec-
tron and X‐ray imaging. Microsc Res Tech. 2014;77:1044–51.
24. Boyde A. Evaluation of laser ablation microtomy for correlative
microscopy of hard tissues. J Microsc. 2018;271:17–30.
25. Taylor SE, Shah M, Orriss IR. Generation of rodent and human os-
teoblasts. Bonekey Rep. 2014;3:585.
26. Zhang LF, Qi J, Zuo G, et al. Osteoblast‐secreted factors promote
proliferation and osteogenic differentiation of bone marrow
stromal cells via VEGF/heme‐oxygenase‐1 pathway. PLoS One.
2014;9:e99946.
27. Smith SJ, Emery R, Pitsillides A, Clarkin CE, Mahajan S. Detection of
early osteogenic commitment in primary cells using Raman spec-
troscopy. Analyst. 2017;142:1962–73.
28. Trevisan J, Angelov PP, Scott AD, Carmichael PL, Martin FL. IR-
ootLab: a free and open‐source MATLAB toolbox for vibrational
biospectroscopy data analysis. Bioinformatics. 2013;29:1095–7.
29. Clarkin CE, Emery RJ, Pitsillides AA, Wheeler‐Jones CP. Evaluation
of VEGF‐mediated signaling in primary human cells reveals a
paracrine action for VEGF in osteoblast‐mediated crosstalk to en-
dothelial cells. J Cell Physiol. 2008;214:537–44.
30. Zhang M, Xuan S, Bouxsein ML, et al. Osteoblast‐specific knockout
of the insulin‐like growth factor (IGF) receptor gene reveals an
essential role of IGF signaling in bone matrix mineralization. J Biol
Chem. 2002;277:44005–12.
31. Elefteriou F, Yang X. Genetic mouse models for bone studies—
strengths and limitations. Bone. 2011;49:1242–54.
32. Schneider P, Krucker T, Meyer E, et al. Simultaneous 3D visual-
ization and quantification of murine bone and bone vasculature
using micro‐computed tomography and vascular replica. Microsc
Res Tech. 2009;72:690–701.
33. Schneider P, Stauber M, Voide R, et al. Ultrastructural properties in
cortical bone vary greatly in two inbred strains of mice as assessed
by synchrotron light based micro‐ and nano‐CT. J Bone Miner Res.
2007;22:1557–70.
34. Schneider P, Voide R, Stampanoni M, Donahue LR, Muller R. The
importance of the intracortical canal network for murine bone
mechanics. Bone. 2013;53:120–8.
35. Thurner PJ, Chen CG, Ionova‐Martin S, et al. Osteopontin deficiency
increases bone fragility but preserves bone mass. Bone. 2010;46:
1564–73.
36. Britz HM, Jokihaara J, Leppanen OV, Jarvinen T, Cooper DM. 3D
visualization and quantification of rat cortical bone porosity using a
desktop micro‐CT system: a case study in the tibia. J Microsc.
2010;240:32–7.
37. Britz HM, Jokihaara J, Leppanen OV, Jarvinen TL, Cooper DM. The
effects of immobilization on vascular canal orientation in rat cort-
ical bone. J Anat. 2012;220:67–76.
38. Callewaert F, Venken K, Kopchick JJ, et al. Sexual dimorphism in cortical
bone size and strength but not density is determined by independent
and time‐specific actions of sex steroids and IGF‐1: evidence from pu-
bertal mouse models. J Bone Miner Res. 2010;25:617–26.
39. Mauras N, Rogol AD, Haymond MW, Veldhuis JD. Sex steroids,
growth hormone, insulin‐like growth factor‐1: neuroendocrine and
metabolic regulation in puberty. Horm Res. 1996;45:74–80.
40. Maes C, Araldi E, Haigh K, et al. VEGF‐independent cell‐autono-
mous functions of HIF‐1alpha regulating oxygen consumption in
fetal cartilage are critical for chondrocyte survival. J Bone Miner
Res. 2012;27:596–609.
41. Zelzer E, McLean W, Ng YS, et al. Skeletal defects in VEGF(120/120)
mice reveal multiple roles for VEGF in skeletogenesis. Develop-
ment. 2002;129:1893–904.
42. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its
receptors. Nat Med. 2003;9:669–76.
43. Harada S, Nagy JA, Sullivan KA, et al. Induction of vascular endo-
thelial growth factor expression by prostaglandin E2 and E1 in
osteoblasts. J Clin Invest. 1994;93:2490–6.
44. Wang DS, Miura M, Demura H, Sato K. Anabolic effects of 1,25‐dihy-
droxyvitamin D3 on osteoblasts are enhanced by vascular endothelial
growth factor produced by osteoblasts and by growth factors pro-
duced by endothelial cells. Endocrinology. 1997;138:2953–62.
45. Bouletreau PJ, Warren SM, Spector JA, et al. Hypoxia and VEGF up‐
regulate BMP‐2 mRNA and protein expression in microvascular
endothelial cells: implications for fracture healing. Plast Reconstr
Surg. 2002;109:2384–97.
46. Alford AI, Kozloff KM, Hankenson KD. Extracellular matrix networks
in bone remodeling. Int J Biochem Cell Biol. 2015;65:20–31.
47. Modder UI, Hoey KA, Amin S, et al. Relation of age, gender, and
bone mass to circulating sclerostin levels in women and men. J
Bone Miner Res. 2011;26:373–9.
48. Haentjens P, Magaziner J, Colon‐Emeric CS, et al. Meta‐analysis:
excess mortality after hip fracture among older women and men.
Ann Intern Med. 2010;152:380–90.
49. Wehren LE, Hawkes WG, Orwig DL, et al. Gender differences in
mortality after hip fracture: the role of infection. J Bone Miner Res.
2003;18:2231–7.
◼ 16 GORING ET AL. Journal of Bone and Mineral Research
